Table 2 Patient characteristics
Variables | Overall (n = 368) | |
|---|---|---|
Age (y) | 75.5 | (63.0, 83.0) |
Male gender | 211 | (57.3) |
Year of admission | ||
2003 ~ 2007 | 28 | (7.6) |
2008 ~ 2012 | 147 | (39.9) |
2013 ~ 2017 | 193 | (52.4) |
Body mass index (kg/ m2) | 23.3 | (20.7, 26.6) |
eGFR (mL/min/1.73 m2) | 58.6 | (45.0, 72.9) |
Hemoglobin (g/dL) | 12.6 | (11.0, 14.3) |
NT-proBNP on admission (ng/L) | 2801.0 | (1149.0, 5897.5) |
LVEF on admission (%) | 43.7 | (29.0, 60.7) |
Require respiratory support | 86 | (23.4) |
Comorbidities | ||
Hypertension | 277 | (75.3) |
Diabetes mellitus | 109 | (29.6) |
Dyslipidemia | 154 | (41.8) |
Atrial fibrillation | 179 | (48.6) |
Ischemic heart disease | 111 | (30.2) |
Valvular disease | 219 | (59.5) |
Smoker | 186 | (50.5) |
History of heart failure admissions before the index admission | 49 | (13.3) |
Medications | ||
ACEI/ARBs | 296 | (80.4) |
Beta-blockers | 266 | (72.3) |
Mineralocorticoid receptor antagonists | 186 | (50.5) |
Loop diuretics | 247 | (67.1) |
Thiazides | 22 | (6.0) |
AHEAD score | ||
0 ~ 1 | 124 | (33.7) |
2 ~ 3 | 215 | (58.4) |
4 ~ 5 | 29 | (7.9) |